Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 5.06% vs -7.93% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 220.54% vs -532.55% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 69.01% vs -34.94% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 112.94% vs 59.27% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Takeda Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 5.06% vs -7.93% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -8.39% vs 14.11% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 220.54% vs -532.55% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 30.41% vs 6.59% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 69.01% vs -34.94% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -9.64% vs 11.72% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 112.94% vs 59.27% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 79.52% vs 0.19% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






